$710,000 of THERMO FISHER SCIENTIFIC INC lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"General discussions related to clinical trials infrastructure and government labs, and related matters. General discussions regarding diagnostic reimbursement policies. H.R. 5269/S. 2761: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025 - all provisions of the bill. H.R. 5343/S. 1717: Ensuring Patient Access to Critical Breakthrough Products Act - all provisions of the bill. H.R. 5304/S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 - provisions regarding FY26 NIH Funding. General discussions regarding government contract thresholds. Preparedness products and services. General discussions around government contracting opportunities. POWER Act; all provisions of the bill. General discussions regarding trade and tariffs, including with respect to markets including China. United States-Mexico-Canada Agreement. General discussions regarding the expiration of key provisions of the 2017 Tax Cuts and Jobs Act, and other tax-related priorities. General discussions regarding impact of U.S. federal government workforce changes on industry."
You can find more data on corporate lobbying on Quiver Quantitative.
TMO Congressional Stock Trading
Members of Congress have traded $TMO stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $TMO stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
TMO Insider Trading Activity
TMO insiders have traded $TMO stock on the open market 66 times in the past 6 months. Of those trades, 0 have been purchases and 66 have been sales.
Here’s a breakdown of recent trading of $TMO stock by insiders over the last 6 months:
- MICHEL LAGARDE (Executive Vice President & COO) has made 0 purchases and 5 sales selling 88,684 shares for an estimated $51,307,290.
- MARC N CASPER (Chairman & CEO) has made 0 purchases and 49 sales selling 38,354 shares for an estimated $21,050,853.
- FREDERICK M. LOWERY (Executive Vice President) has made 0 purchases and 2 sales selling 13,825 shares for an estimated $8,154,131.
- MICHAEL D SHAFER (Executive Vice President) has made 0 purchases and 3 sales selling 12,332 shares for an estimated $7,237,535.
- LISA P. BRITT (Sr. VP and Chief HR Officer) has made 0 purchases and 3 sales selling 11,282 shares for an estimated $6,466,985.
- GIANLUCA PETTITI (Executive Vice President) has made 0 purchases and 4 sales selling 3,775 shares for an estimated $2,171,640.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
TMO Hedge Fund Activity
We have seen 1,116 institutional investors add shares of TMO stock to their portfolio, and 1,205 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- J. STERN & CO. LLP added 31,455,105 shares (+58006.4%) to their portfolio in Q4 2025, for an estimated $18,226,660,592
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 7,231,281 shares (-74.9%) from their portfolio in Q4 2025, for an estimated $4,190,165,775
- AUTO-OWNERS INSURANCE CO removed 2,423,706 shares (-99.8%) from their portfolio in Q1 2026, for an estimated $1,169,377,552
- FMR LLC added 2,199,538 shares (+29.0%) to their portfolio in Q4 2025, for an estimated $1,274,522,294
- ROCKEFELLER CAPITAL MANAGEMENT L.P. added 2,147,137 shares (+633.6%) to their portfolio in Q4 2025, for an estimated $1,244,158,534
- ROYAL BANK OF CANADA added 1,313,517 shares (+48.2%) to their portfolio in Q4 2025, for an estimated $761,117,425
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,230,872 shares (+19.0%) to their portfolio in Q4 2025, for an estimated $713,228,780
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
TMO Analyst Ratings
Wall Street analysts have issued reports on $TMO in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 01/30/2026
- Citigroup issued a "Buy" rating on 12/11/2025
- Goldman Sachs issued a "Buy" rating on 12/09/2025
- HSBC issued a "Buy" rating on 12/01/2025
- Argus Research issued a "Buy" rating on 10/29/2025
- Morgan Stanley issued a "Overweight" rating on 10/28/2025
- TD Cowen issued a "Buy" rating on 10/23/2025
To track analyst ratings and price targets for TMO, check out Quiver Quantitative's $TMO forecast page.
TMO Price Targets
Multiple analysts have issued price targets for $TMO recently. We have seen 13 analysts offer price targets for $TMO in the last 6 months, with a median target of $670.0.
Here are some recent targets:
- Luke Sergott from Barclays set a target price of $625.0 on 04/14/2026
- Vijay Kumar from Evercore ISI Group set a target price of $575.0 on 04/06/2026
- Dan Brennan from TD Cowen set a target price of $683.0 on 01/30/2026
- Patrick Donnelly from Citigroup set a target price of $685.0 on 01/30/2026
- Daniel Arias from Stifel set a target price of $700.0 on 01/09/2026
- Brandon Couillard from Wells Fargo set a target price of $675.0 on 12/15/2025
- Evie Koslosky from Goldman Sachs set a target price of $685.0 on 12/09/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
